Cybin Inc. (CYBN)
(Delayed Data from AMEX)
$10.03 USD
+0.04 (0.44%)
Updated Nov 4, 2024 02:33 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CYBN 10.03 +0.04(0.44%)
Will CYBN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CYBN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CYBN
What Makes Cybin Inc. (CYBN) a New Buy Stock
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround
CYBN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?
Brian's Big Idea on Biotech
Other News for CYBN
Cybin’s Promising Growth in the Psychedelic Sector Justifies Buy Rating
Cybin Inc: Another High-Risk Psychedelics Play
Cybin to Highlight Innovations at Health Summit
Rising High: RIV Capital provides update on revenue, synergy realization
Rising High: RIV Capital provides update on revenue, synergy realization